News | September 02, 2010

Radiofrequency Ablation for AF May Cause Esophageal Injury

September 2, 2010 – New research released this week is the first to find both anatomical and procedural considerations that can lead to the creation of esophageal ulcerations (ESUL) after radiofrequency ablation of atrial fibrillation (AF). According to a study published in the September issue of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, patients at high risk for esophageal injury can be identified based on pre-acquired multi-slice computed tomography. The study is the largest to provide serial endoscopy data on the esophagus after radiofrequency ablation.

The study population consisted of 275 patients admitted to the Elisabethinen University Teaching Hospital Linz for pulmonary vein (PV) isolation from September 2007 to June 2009. A standardized ablation approach using a 25-W energy maximum at the posterior left atrial (LA) wall without esophagus visualization, temperature monitoring or intracardiac ultrasound was performed. All patients were screened for evidence of the development of ESUL 24 hours after RFA. ESUL did not develop in any patient who had PV isolation alone.

Study analysis revealed that the greatest anatomical risk factor for the development of ESUL was a small LA-to-esophageal distance. Within the study population, the total risk of ulcers developing was 2.2 percent. Wall legions were classified as ESUL created by radiofrequency ablation by means of localization and endosonographic appearance. Anatomical factors included in the multivariate model were LA-to-esophageal distance, type of AF and additional LA linear lesions. LA-to-esophageal distance was the only independent predictor of the development of ESUL.

“It has been speculated that esophageal ulcerations can lead to atrioesophageal fistula, which is a rare but life-threatening complication of AF,” said lead author Martin Martinek, M.D., Public Hospital Elisabethinen, Academic Teaching Hospital of the University of Innsbruck and Graz in Austria. “Our study aimed to discover risk factors that can lead to injuries of the esophagus due to radiofrequency ablation. In doing so, we may better identify high-risk patients to determine the most appropriate course of action for RFA and its followup.”

For more information: www.heartrhythmjournal.com

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
Overlay Init